Trademark: 90065058
Word
SYNGENE SYNVENT
Status
Registered
Status Code
700
Status Date
Tuesday, April 5, 2022
Serial Number
90065058
Registration Number
6695032
Registration Date
Tuesday, April 5, 2022
Mark Type
3000
Filing Date
Tuesday, July 21, 2020
Published for Opposition
Tuesday, June 1, 2021

Trademark Owner History
Syngene International Limited - Original Registrant

Classifications
44 Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes
42 Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry
The mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle.

Trademark Events
Apr 5, 2022
Registered-Principal Register
Mar 4, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 3, 2022
Allowed Principal Register - Sou Accepted
Feb 15, 2022
Statement Of Use Processing Complete
Jan 27, 2022
Use Amendment Filed
Feb 14, 2022
Case Assigned To Intent To Use Paralegal
Jan 27, 2022
Teas Statement Of Use Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 29, 2021
Approved For Pub - Principal Register
Apr 29, 2021
Examiner's Amendment Entered
Apr 29, 2021
Notification Of Examiners Amendment E-Mailed
Apr 29, 2021
Examiners Amendment E-Mailed
Apr 29, 2021
Examiners Amendment -Written
Nov 9, 2020
Notification Of Non-Final Action E-Mailed
Nov 9, 2020
Non-Final Action E-Mailed
Nov 9, 2020
Non-Final Action Written
Nov 4, 2020
Assigned To Examiner
Aug 19, 2020
Notice Of Design Search Code E-Mailed
Aug 18, 2020
New Application Office Supplied Data Entered In Tram
Jul 29, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 29, 2020
Teas Change Of Correspondence Received
Jul 29, 2020
Teas Change Of Owner Address Received
Jul 24, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24